Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection

British Journal of Surgery

Volumn 97, Issue 9, 2010, Pages 1331-1339

  De Meijer, V E ^a,b   Kalish, B T ^a   Puder, M ^a   IJzermans, J N M ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY LIVER; HUMAN; LIVER RESECTION; META ANALYSIS; MORTALITY; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

FATTY LIVER; HEPATECTOMY; HUMANS; RISK FACTORS; TREATMENT OUTCOME;

EID: 77956404177     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7194     Document Type: Review

References (41)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231.
2. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387-1395. (Pubitemid 39657013)
3. Bellentani S, Saccoccio G, Masutti F, Crocè LS, Brandi G, Sasso F et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000; 132: 112-117. (Pubitemid 30044177)
4. Al-Asfoor A, Fedorowicz Z, Lodge M. Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases. Cochrane Database Syst Rev 2008; (2)CD006039. (Pubitemid 351807418)
5. Verslype C, Van Cutsem E, Dicato M, Arber N, Berlin JD, Cunningham D et al. The management of hepatocellular carcinoma.. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008. Ann Oncol 2009; 20(Suppl 7): Vii1-Vii6.
6. Aljiffry M, Abdulelah A, Walsh M, Peltekian K, Alwayn I, Molinari M. Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature. J Am Coll Surg 2009; 208: 134-147.
7. Petrowsky H, Busuttil RW. Evolving surgical approaches in liver transplantation. Semin Liver Dis 2009; 29: 121-133.
8. Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 2003; 138: 1198-1206. (Pubitemid 37392393)
9. Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 1999; 229: 322-330. (Pubitemid 30191766)
10. Yamanaka N, Okamoto E, Oriyama T, Fujimoto J, Furukawa K, Kawamura E et al. A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use. Ann Surg 1994; 219: 342-346. (Pubitemid 24121446)
11. Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery. Semin Liver Dis 2001; 21: 105-113.
12. Veteläinen R, van Vliet A, Gouma DJ, van Gulik TM. Steatosis as a risk factor in liver surgery. Ann Surg 2007; 245: 20-30. (Pubitemid 46035431)
13. Cho JY, Suh KS, Kwon CH, Yi NJ, Lee KU. Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired. Surgery 2006; 139: 508-515.
14. Angulo P. Nonalcoholic fatty liver disease and liver transplantation. Liver Transpl 2006; 12: 523-534.
15. Adam R, Hoti E. Liver transplantation: the current situation. Semin Liver Dis 2009; 29: 3-18.
16. Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B et al. Oxford Centre for Evidence-based Medicine, Levels of Evidence (March 2009). http://www.cebm.net/index.aspx?o=1025 [accessed 9 June 2009].
17. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M et al. The Newcastle -Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Ottawa Health Research Institute. http://www.ohri.ca/ programs/clinical-epidemiology/oxford.htm [accessed 9 June 2010].
18. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
19. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
20. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
21. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointcst Surg 1998; 2: 292-298. (Pubitemid 128409616)
22. Kooby DA, Fong Y, Suriawinata A, Gonen M, Allen PJ, Klimstra DS et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 2003;7:1034-1044. (Pubitemid 37524071)
23. Gomez D, Malik HZ, Bonney GK, Wong V, Toogood GJ, Lodge JP et al. Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg 2007; 94: 1395-1402. (Pubitemid 350144389)
24. McCormack L, Petrowsky H, Jochum W, Furrer K, Clavien PA. Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg 2007; 245: 923-930. (Pubitemid 46809294)
25. Nagai S, Fujimoto Y, Kamei H, Nakamura T, Kiuchi T. Mild hepatic macrovesicular steatosis may be a risk factor for hyperbilirubinaemia in living liver donors following right hepatectomy. Br J Surg 2009; 96: 437-444.
26. Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med. 2007; 356: 1545-1559. (Pubitemid 46588419)
27. McCormack L, Capitanich P, Quiñonez E. Liver surgery in the presence of cirrhosis or steatosis: is morbidity increased? Patient Saf Surg 2008; 2: 8.
28. Egger M, Schneider M, Davey Smith G. Spurious precision? Meta-analysis of observational studies. BMJ 1998; 316: 140-144. (Pubitemid 28121116)
29. Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol 1992; 45: 255-265.
30. El-Badry AM, Breitenstein S, Jochum W, Washington K, Paradis V, Rubbia-Brandt L et al. Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 2009; 250: 691-697.
31. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009; 250: 187-196.
32. Strasberg SM, Linehan DC, Hawkins WG. The Accordion severity grading system of surgical complications. Ann Surg 2009;250:177-186.
33. Clavien PA, Strasberg SM. Severity grading of surgical complications. Ann Surg 2009; 250: 197-198.
34. Pringle JH. Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg 1908; 48: 541-549.
35. Gurusamy KS, Kumar Y, Ramamoorthy R, Sharma D, Davidson BR. Vascular occlusion for elective liver resections. Cochrane Database Syst Rev 2009; (1)CD007530.
36. Little SA, Jarnagin WR, DeMatteo RP, Blumgart LH, Fong Y. Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer. J Gastrointest Surg 2002; 6: 88-94. (Pubitemid 40433594)
37. Mullen JT, Moorman DW, Davenport DL. The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg 2009; 250: 166-172.
38. Dindo D, Muller MK, Weber M, Clavien PA Obesity in general elective surgery. Lancet 2003; 361: 2032-2035. (Pubitemid 36695045)
39. Aloia T, Sebagh M, Plasse M, Karam V, Lévi F, Giacchetti S et al. Liver histology and surgical outcomes after preoperative chemotherapy with fiuorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 2006; 24: 4983-4990. (Pubitemid 46631400)
40. Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. BrJ Surg 2007; 94: 274-286.
41. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994; 309: 1286-1291.